CCCS OKs Tamarind Health's TalkMed Group acquisition

The parties overlap on the provision of private medical oncology services in Singapore.

The Competition and Consumer Commission of Singapore (CCCS) has cleared the proposed acquisition of TalkMed Group by Tamarind Health on 27 June.

CCCS said that the proposed transaction will not infringe the section 54 prohibition of the act, which prohibits mergers that may substantially lessen competition within any market in Singapore.

It assessed that the parties overlap on the provision of private medical oncology services in Singapore.

CCCS also noted that there are alternative providers of medical oncology services in both the private and public sectors in Singapore.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia